Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

BSH 2019 | The top acute leukemia abstracts at BSH 2019

Steven Knapper • 2 Apr 2019
BSH 2019
Acute Myeloid Leukemia Leukemia CPX-351 Cytarabine Daunorubicin

Steven Knapper, DM, FRCPath, MRCP, BMBCh, Cardiff University, Cardiff, Wales, UK, speaks at the British Society for Haematology (BSH) 2019 Annual Meeting, held in Glasgow, UK, where he discusses the top acute leukemia abstracts from the meeting.

More from Steven Knapper

1:12
The value of FLT3 inhibitors in AML and focus for future trial designs
Steven Knapper • 24 Apr 2023
2:09
Advances in the management of fit adults with AML
Steven Knapper • 24 Apr 2023
2:22
Session highlights: IDH inhibitors, salvage regimens, and other novel developments in AML
Steven Knapper • 24 Apr 2023
3:59
The challenges of post-MPN AML
Steven Knapper • 15 Nov 2019

Related Videos

2:06
Managing relapsed ALL: the role of novel cellular therapies & importance of conditioning regimens
Christina Peters • 15 Apr 2024
1:14
Promising novel agents in AML: menin inhibitors
Mark Levis • 16 Apr 2024
3:02
EUPLAGIA-1: Phase I trial of GLPG5201, a CD19 CAR-T product, in R/R CLL and Richter's transformation
Valentin Ortiz-Maldonado • 16 Apr 2024
1:48
Do all patients require maintenance therapy following alloSCT?
Mark Levis • 16 Apr 2024
The content of VJHemOnc is intended for healthcare professionals